Organization · Other
CCRM
CCRM (Centre for Commercialization of Regenerative Medicine) is a Canadian not-for-profit organization based in Toronto, focused on advancing regenerative medicine and cell and gene therapies through collaboration with academia and industry.
Overview
What CCRM does
What CCRM is
CCRM (Centre for Commercialization of Regenerative Medicine) is a Canadian not-for-profit organization based in Toronto, focused on advancing regenerative medicine and cell and gene therapies through collaboration with academia and industry.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find CCRM elsewhere
Open the official website or a supported primary organization account.
Capability profile
CCRM as a funder
Investment thesis
CCRM focuses on advancing the commercialization of regenerative medicine and cell and gene therapies through collaboration with industry partners, academic institutions, and government agencies.
Focus narrative
CCRM invests in and provides services related to regenerative medicine and cell and gene therapy. Their focus encompasses various sectors, particularly biotechnology and healthcare, targeting the development and commercialization of therapies at different stages. While primarily operating in Canada, CCRM also engages in international collaborations.
Value beyond capital
CCRM offers a range of programs and resources to support innovation in regenerative medicine, including incubation programs for early-stage companies and strategic assistance through their Venture by Design initiative.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- Ca · Global
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
CCRM has a diverse portfolio of companies involved in regenerative medicine and cell and gene therapy. Notable companies include Notch Therapeutics, which focuses on developing engineered T cell therapies, and BlueRock Therapeutics, specializing in cell therapies for neurological diseases.
Capability profile
CCRM as an event host
Event focus
CCRM (Centre for Commercialization of Regenerative Medicine) is dedicated to advancing the commercialization of regenerative medicine and cell and gene therapies. Founded in 2011 and based in Toronto, Canada, CCRM supports the development and manufacturing of innovative therapies through collaboration with industry partners, academic institutions, and government agencies.
Format narrative
CCRM organizes and supports various events, conferences, and workshops aimed at fostering collaboration and knowledge sharing in the regenerative medicine sector.
Participant value
CCRM provides resources and support for early-stage companies in regenerative medicine, helping them refine their business models and strategies while facilitating collaboration across the industry.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Regions
- Canada
Capability profile
CCRM as a publisher
Editorial focus
CCRM (Centre for Commercialization of Regenerative Medicine) is dedicated to advancing the commercialization of regenerative medicine and cell and gene therapies. Founded in 2011 and based in Toronto, Canada, CCRM collaborates with industry partners, academic institutions, and government agencies to support the development and manufacturing of innovative therapies.
Audience value
CCRM provides essential support and resources for the development and commercialization of regenerative medicine therapies, fostering collaboration among industry, academia, and government.
Format and cadence
- Content formats
- podcast and blog
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Regions
- Canada
Flagship work and coverage
Flagship properties
CCRM produces a podcast discussing topics related to regenerative medicine and cell therapy, and maintains the Signals Blog, which provides insights and updates on industry trends and research.
Common questions
What to know about CCRM
Upseed classifies CCRM under the Other organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.